John Libbey Eurotext

Journal de Pharmacie Clinique

Achieving competency as an advanced paediatric and neonatal pharmacist: description of the long distance web based course offered at Liverpool John Moores University (LJMU) Volume 36, issue 3, Septembre 2017

Figures

  • Figure 1
Author
Paediatric teacher practitioner, Liverpool John Moores University's (LJMU), School of pharmacy and biomolecular sciences and lead paediatric rheumatology pharmacist at the Alder Hey Children's Hospital NHS Foundation trust, Liverpool, United Kingdom
* Reprints
  • Key words: paediatrics, CPD, distance learning, master, pharmaceutical care
  • DOI : 10.1684/jpc.2017.0361
  • Page(s) : 127-32
  • Published in: 2017

The paediatric population has been recognised by the NPSA (National patient safety agency) as a high risk group due to its varying pharmacokinetic and pharmacodynamic parameters. Appropriate training, both at undergraduate and postgraduatelevel is therefore, paramount. The postgraduate team at the LJMU School of pharmacy in partnership with the Alder Hey Children's NHS foundation trust has identified there is little opportunity for pharmacists wishing to develop paediatric advanced practice in the United Kingdom (UK) and in Europe. The aim of this paper is to introduce a distance learning programme for pharmacists and other health care professionals who wish to develop their role or expand their knowledge and expertise in pharmaceutical care for children and neonates. This masters continuing professional development (MCPD) course will provide pharmacists with the necessary skills, expertise and knowledge to develop their role in the safe and effective use of medicines in children and neonates and will support the Advanced Level 1 and some Level 2 competencies suggested by the Neonatal and paediatric pharmacist group (NPPG) in the UK. The course will be awarded 20 credits.